In this free webinar, learn how alternative purification strategies can support the development of bispecifics and other complex biologics. The featured speaker will discuss selective capture, charge-based polishing and mixed-mode chromatography approaches for addressing challenging impurity profiles. Attendees will also explore how these approaches can expand separation options and support more efficient process-development decisions when working with limited development material.
TORONTO, Aug. 20, 2026 /PRNewswire/ — As bispecifics and other complex biologics move through clinical development and into commercial programmes, downstream teams are under increasing pressure to deliver purification processes that are selective, scalable and efficient. These challenging molecules often bring impurity profiles that are difficult to resolve using standard monoclonal antibody platform approaches, from product-related variants and aggregates to host cell proteins and other closely related impurities.
This webinar will explore how an outcome-led purification strategy, rather than a platform strategy, can help accelerate process development for complex biologics while balancing impurity clearance, recovery and process understanding. The session will begin with selective capture strategies that can create more options beyond standard platform approaches. It will then move to polishing, including the growing role of mixed-mode chromatography, also referred to as multimodal chromatography, for impurity profiles that may require different separation mechanisms before scale-up.
Through case studies, the presentation will highlight selective capture of Fc and non-Fc antibodies, high-molecular-weight intermediate polish and targeted HCP polish screening as examples of how different purification approaches can support a more purposeful downstream development strategy. Attendees will see how differentiated mixed-mode chromatography can help reveal purification options that may be missed by standard platform screens, particularly where closely related impurities challenge conventional approaches.
Register for this webinar to learn how bispecific purification strategies can expand separation options, improve impurity clearance and build confidence before scale-up.
Join Maelia Uy-Gomez, Field Application Scientist, Astrea Bioseparations, for the live webinar on Thursday, September 17, 2026, at 10am EDT (4pm CEST / EU-Central).
For more information, or to register for this event, visit Expand Bispecific Purification Strategies Beyond mAb Platforms.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/expand-bispecific-purification-strategies-beyond-mab-platforms-upcoming-webinar-hosted-by-xtalks-302855885.html
SOURCE Xtalks
